Aldose Reductase Inhibitors Reduce Skin Cell Aging
Author Information
Author(s): Yepuri Gautham, Kancharla Kushie, Perfetti Riccardo, Shendelman Shoshana, Wasmuth Andrew, Ramasamy Ravichandran
Primary Institution: New York University School of Medicine
Hypothesis
Can aldose reductase inhibitors attenuate human keratinocyte senescence?
Conclusion
The study found that aldose reductase inhibitors significantly reduce markers of senescence in human keratinocytes.
Supporting Evidence
- All three aldose reductase inhibitors significantly inhibited assessed senescent markers after senescence induction.
- Treatment with ARIs prevented high glucose induced senescence by significantly reducing SA-β-gal staining.
- ARIs also downregulated gene expression of key senescence markers such as CDKN1A, TP53, and SERPINE.
Takeaway
This study shows that certain drugs can help keep skin cells young and healthy by stopping them from aging too quickly.
Methodology
The study involved treating normal human keratinocytes with aldose reductase inhibitors and measuring various senescence markers after inducing senescence with high glucose, hydrogen peroxide, and mitomycin-C.
Participant Demographics
Normal pooled adult human epidermal keratinocytes were used.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website